Audrey F. Jakubowski
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Audrey F. Jakubowski
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million.
19
| Subsidiary | Pharmaceuticals: Major | 19 |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA.
16
| Extinct | Pharmaceuticals: Major | 16 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.
3
| Extinct | Medical/Nursing Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Audrey F. Jakubowski tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | President Chief Executive Officer Director of Finance/CFO | |
| GT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Chairman Chief Tech/Sci/R&D Officer General Counsel | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KINEMED INC | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder Founder | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Director/Board Member Graduate Degree Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer | |
Eurogen Ltd
 Eurogen Ltd Packaged SoftwareTechnology Services Part of Servoca Plc, Eurogen Ltd designs software. The company is based in Pulborough, UK. Eurogen was acquired by Multi Group Plc on December 11, 2000 for $0.40 million. | Packaged Software | Chairman | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
| Loyola Marymount University | College/University | Undergraduate Degree Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| New York University | College/University | Graduate Degree Undergraduate Degree | |
| Princeton University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Philadelphia Museum of Art
 The Philadelphia Museum of Art Other Consumer ServicesConsumer Services The Philadelphia Museum of Art operates as a not-for-profit organization and supported by endowments, voluntary gifts, corporate support, private foundation grants, and state and federal grants, as well as from admissions, membership fees, and merchandise sales. The firm is showcasing human creativity in painting, sculpture, and works on paper, decorative arts and architectural settings from Asia, Europe, and Latin America. The company was founded in 1874 and is headquartered in Philadelphia, PA. | Other Consumer Services | Director/Board Member Director/Board Member | |
AAON Coil Products, Inc.
 AAON Coil Products, Inc. Industrial MachineryProducer Manufacturing Part of AAON, Inc., AAON Coil Products, Inc. manufactures and markets air-conditioning and heating equipment. The company is based in Longview, TX. Gary D. Fields has been the CEO of the company since 2018. | Industrial Machinery | Corporate Officer/Principal Corporate Officer/Principal | |
| PrimeTech Partners | Founder Founder | ||
| International Academy of Trial Lawyers | President Corporate Officer/Principal | ||
| Loyola Law School | College/University | Graduate Degree Graduate Degree | |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Chief Executive Officer | |
| VERASTEM, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Chief Executive Officer General Counsel | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Chairman Corporate Officer/Principal | |
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Biotechnology | Founder Founder | |
Xyphos Biosciences, Inc.
 Xyphos Biosciences, Inc. BiotechnologyHealth Technology Xyphos Biosciences, Inc. engages in biotechnology business. The firm’s novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform allows new ways to mobilize and control immune cells to find and destroy specifically targeted cells throughout the body. The company was founded by David W. Martin, Jr. and James L. Knighton and is headquartered in South San Francisco, CA. | Biotechnology | Founder Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Regno Unito | 3 |
| Svizzera | 2 |
| Irlanda | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Technology Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 173 |
| Corporate Officer/Principal | 130 |
| Independent Dir/Board Member | 57 |
| President | 55 |
| Chief Tech/Sci/R&D Officer | 50 |
Contatti più connessi
| Insiders | |
|---|---|
| Osagie Imasogie | 37 |
| Robert Stein | 34 |
| Bobby Sandage | 29 |
| James Manuso | 29 |
| Michael Perry | 28 |
| Charles Casamento | 27 |
| John E. Osborn | 27 |
| Errol de Souza | 21 |
| Paul Friedman | 21 |
| Allan R. Goldberg | 20 |
| Gregory Berk | 17 |
| David W. Martin | 16 |
| Thomas V. Girardi | 16 |
| Rajesh Shrotriya | 16 |
| Joseph Rubinfeld | 14 |
- Borsa valori
- Insiders
- Audrey F. Jakubowski
- Connessioni Società
